Viridian Therapeutics, Inc. (VRDN): Shareholders' Equity
$722.17M
As of 2025-12-31
$662.10M
As of 2026-06-30
+22.3%
3-year compound annual growth
+43.2%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $722.17M | +7.5% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $671.64M | +51.9% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $442.02M | +11.9% | 2026-02-26, Balance as of period end |
| 2022-12-31 | $395.06M | +110.5% | 2025-03-03, Balance as of period end |
| 2021-12-31 | $187.72M | +56.4% | 2024-02-27, Balance as of period end |
| 2020-12-31 | $120.04M | +661.9% | 2022-03-11, Balance as of period end |
| 2019-12-31 | $15.75M | -69.3% | 2021-03-26, Balance as of period end |
| 2018-12-31 | $51.34M | +33.3% | 2020-03-13, Balance as of period end |
| 2017-12-31 | $38.51M | n/m | 2019-03-14, Balance as of period end |
| 2016-12-31 | -$61.92M | n/m | 2018-03-15, Balance as of period end |
| 2015-12-31 | $10.41M | +73.8% | 2017-03-24, Balance as of period end |
| 2014-12-31 | $5.99M | n/m | 2016-03-21, Balance as of period end |
| 2013-12-31 | -$23.89M | n/a | 2015-03-27, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | $722.17M | +7.5% |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | $206.75M | +519.8% |
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | $36.98M | +13.5% |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | $609.98M | -23.1% |
| Kura Oncology, Inc. (KURA) | 2025-12-31 | $174.13M | -57.9% |
| AbCellera Biologics Inc. (ABCL) | 2025-12-31 | $966.90M | -8.4% |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $59.02M | +28.0% |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | $99.01M | n/m |
| Enanta Pharmaceuticals Inc (ENTA) | 2025-09-30 | $64.72M | -49.8% |
Compare VRDN, ASMB, RMTI, BCYC side by side · Screen every company in Pharmaceutical Preparations ↗